Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P677: Azathioprine dosing and metabolite measurement in paediatric inflammatory bowel disease—does one size fit all?ECCO '18 Vienna
Year: 2018
Authors:

R. Tresman*, M. Mutalib, J. Kammermeier, R. Vora

Evelina London Children's Hospital, London, UK

P678: Risk of malnutrition in patients with inflammatory bowel diseases: Results from an Italian multi-centre observational cross-sectional studyECCO '18 Vienna
Year: 2018
Authors:

C. Viganò1*, A. Losco2, I. Bergna1, G. Meucci3, A. Amato4, GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali)

1UOC Gastroenterologia ASST Monza Ospedale San Gerardo - International Center for Digestive Health University of Milan Bicocca, UOC Gastroenterologia ASST Monza, Monza, Italy, 2San Paolo Hospital ASST Santi Paolo e Carlo, UO Medicina VI Hepatology and Gastroenterology, Milano, Italy, 3San Giuseppe Hospital, Division of Gastroenterology, Milano, Italy, 4Valduce Hospital, Division of Gastroenterology, Como, Italy

P679: Risk factors for disease relapse after stepping down from combination to anti-TNF monotherapy in children with IBDECCO '18 Vienna
Year: 2018
Authors:

A. Yerushalmy-Feler*, S. Cohen

“Dana-Dwek” Children's Hospital, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, The Pediatric Gastroenterology Unit, Tel Aviv, Israel

P680: Machine learning (ML) in RCU-operated patients: Can we predict postoperative complications?ECCO '18 Vienna
Year: 2018
Authors:

L. Sofo*, P. Caprino, A.E. Potenza, F. Sacchetti, C.A. Schena

Fondazione Policlinico Gemelli, Rome, Italy

P681: Systematic review and meta-analysis of the safety and efficacy of intra-fistular injections of mesenchymal stem cells in clinical trials and observational cohort studiesECCO '18 Vienna
Year: 2018
Authors:

R. Ciccocioppo1*, C. Klersy2, D. Leffler3, R. Rogers3, D. Bennett3, G.R. Corazza4

1University of Verona, Department of Medicine, Verona, Italy, 2Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 3Takeda Pharmaceutical Company Limited, Boston, USA, 4Fondazione IRCCS Policlinico San Matteo, Department of Clinical Medicine I, Pavia, Italy

P682: Role of laboratory markers in paediatric inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

R. Shentova*, P. Yaneva, M. Baycheva, P. Hadjiiski, D. Kofinova, C. Zhelev

University Paediatric Hospital “Prof. Ivan Mitev”, Gastroenterology and Hepatology, Sofia, Bulgaria

P683: Maintenance of deep remission in patients with ulcerative colitis treated with thiopurines after withdrawal of the drug: Perspective real-life experience of a single centreECCO '18 Vienna
Year: 2018
Authors:

M. Mazza*, C. Praticò, M. Salice, A. Calafiore, L. Calandrini, C. Calabrese, M. Campieri, F. Rizzello, P. Gionchetti

Policlinico Sant'Orsola Malpighi, Bologna, Italy

P684: Sleep disturbances in IBD patients without sedative therapyECCO '18 Vienna
Year: 2018
Authors:

G.E. Gilca-Blanariu1,2*, G. Stefanescu1,2, M. Ciocoiu2

1''Sf Spiridon'' County Clinical Emergency Hospital, Gastroenterology, Iasi, Romania, 2''Grigore T. Popa'' University of Medicine and Pharmacy, Iasi, Romania

P685: Patient’s performance and feedback by using home test faecal calprotectin as an objective reported outcomeECCO '18 Vienna
Year: 2018
Authors:

S.C. Wei*

National Taiwan University Hospital and College of Medicine, Department of Internal Medicine, Taipei, Taiwan

P686: Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn’s disease patients: PRACTICROHN studyECCO '18 Vienna
Year: 2018
Authors:

M. Barreiro-de Acosta1*, V. García2, A. Gutiérrez3, M.D. Martín Arranz4, M. Iborra5, C. Taxonera6, C. Romero7, B. Juliá7, L. Cea-Calvo7, E. Domènech8

1Complejo Hospitalario Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain, 2Hospital Universitario Reina Sofia, Unidad Clinica de Aparato Digestivo, Cordoba, Spain, 3Hospital General Universitario Alicante, Gastroenterology unit, Alicante, Spain, 4Hospital Universitario La Paz, Gastroenterology Unit, Madrid, Spain, 5Servicio de Gastroenterologia, Hospital La Fe, Valencia, Spain, 6Hospital Clinico San Carlos, Gastroenterology Unit, Madrid, Spain, 7MSD Spain, Medical Department, Madrid, Spain, 8Hospital Universitari Germans Trias i Pujol and CIBERehd, Gastroenterology Unit, Badalona, Spain

P687: Female sex is associated with discontinuation of subcutaneous anti-TNF therapy for side effects in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

J. Schultheiss*, E. Lamers, E. Brand, H. Fidder

UMC Utrecht, Gastroenterology, Utrecht, The Netherlands

P688: Demographic, clinical, and therapeutic characteristics of a cohort of 238 patients with ulcerative colitis from two medical centres from UruguayECCO '18 Vienna
Year: 2018
Authors:

M.J. Luciano1, A. Noria2, B. Iade1,3*

1Hospital de Clínicas, Gastroenterology, Montevideo, Uruguay, 2Hospital de Clnicas, Metodos, Montevideo, Uruguay, 3Grupo Uruguayo de Trabajo en Enfermedad Inflamatoria IntestinalL, Montevideo, Uruguay

P689: UK Asians are prescribed vedolizumab earlier in disease history than Caucasians, but respond equally well to therapyECCO '18 Vienna
Year: 2018
Authors:

H. Gordon1*, R. Gadhok1, A. Ibarra1,2, J.O. Lindsay1,3

1Royal London Hospital, Gastroenterology, London, UK, 2Barth Health, London, UK, 3The Blizard Institute, Centre for Immunology, Barts and the London School of Medicine, London, UK

P690: Clinical and endoscopic outcomes of one year golimumab treatment in patients with active ulcerative colitis: A real-life observational studyECCO '18 Vienna
Year: 2018
Authors:

S. Berends1,2*, A. Strik2, J. Jansen3, N. de Boer4, J. Brandse4, G. D'Haens2, R. Mathôt1, M. Löwenberg2

1Academic Medical Center (AMC), Hospital Pharmacy, Amsterdam, The Netherlands, 2Academic Medical Center (AMC), Gastroenterology and Hepatology, Amsterdam, The Netherlands, 3Onze Lieve Vrouwe Gasthuis, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 4VU University Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands

P691: Cx601, a novel stem cell therapy for complex perianal fistulas in Crohn’s disease has rapid onset of clinical remission and low relapse rate by week 52ECCO '18 Vienna
Year: 2018
Authors:

D. García-Olmo1, J. Panés2*, N. Brayshaw3, M.P. Richard4, C. Agboton5

1Faculty of Medicine, Autonomous University of Madrid, Department of Surgery, Madrid, Spain, 2Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Gastroenterology Department, Barcelona, Spain, 3Takeda Pharmaceuticals International, London, UK, 4TiGenix S.A.U., Tres Cantos, Madrid, Spain, 5Takeda Pharmaceuticals International AG, Zurich, Switzerland

P692: Efficacy and safety of early biologic treatment of Crohn’s disease in adult and paediatric patients: A systematic reviewECCO '18 Vienna
Year: 2018
Authors:

J.-F. Colombel1*, R. Ungaro1, S. Aggarwal2, O. Topaloglu2, M. Skup3, W.-J. Lee3

1Icahn School of Medicine at Mount Sinai, New York, USA, 2NOVEL Health Strategies, Bethesda, USA, 3AbbVie Inc., North Chicago, USA

P693: Should extraintestinal manifestations (EIMs) be part of disease activity assessment in ulcerative colitis?ECCO '18 Vienna
Year: 2018
Authors:

A. Walsh1, A. Kormilitzin2, C. Hinds3, V. Sexton4, J. Wilson1, O. Brain1*, S. Keshav1, H. Uhlig1, J. Geddes4, G. Goodwin4, M. Peters5, G. Collins6, S. Travis1

1John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, UK, 2Mathematical Institute, Oxford, UK, 3Big Data Institute, Oxford, UK, 4University of Oxford, Psychiatry Department, Oxford, UK, 5University of Oxford, Nuffield Department of Population Health, Oxford, UK, 6University of Oxford, Centre for Statistics in Medicine, Oxford, UK

P694: Non-medical mandatory reversed and back and forth switch between infliximab and its biosimilar: Early clinical outcomesECCO '18 Vienna
Year: 2018
Authors:

A. Ilias1*, K. Szanto2, L. Gonczi1, Z. Kurti1, P.A. Golovics3, E. Schafer3, K. Farkas2, T. Szamosi3, Z. Szepes2, T. Molnar2, A. Vincze4, P.L. Lakatos1,5

1Semmelweis University, First Department of Medicine, Budapest, Hungary, 2University of Szeged, First Department of Internal Medicine, Szeged, Hungary, 3Military Hospital – State Health Centre, Gastroenterology Unit, Budapest, Hungary, 4University of Pécs, 1st Department of Medicine, Pecs, Hungary, 5Mcgill University Health Center, Department of Gastroenterology, Montreal, Canada

P695: Does anticoagulation treatment increase the rate of major bleeding complications in patients with IBD and venous thromboembolism?ECCO '18 Vienna
Year: 2018
Authors:

G. Novacek1*, S. Tonko1, A. Sobala1, H. Tilg2, W. Petritsch3, W. Reinisch1, A. Mayer4, T. Haas5, O. Ludwiczek6, T. Feichtenschlager7, H. Fuchssteiner8, P. Steiner9, H. Vogelsang1, W. Miehsler10, R. Platzer11, W. Tillinger12, A. Schmid13, B. Blaha14, H. Herkner15

1Medical University of Vienna, Department of Internal Medicine III, Vienna, Austria, 2Medical University of Innsbruck, Department of Internal Medicine I, Innsbruck, Austria, 3Medical University of Graz, Department of Gastroenterology and Hepatology, Graz, Austria, 4Universitätsklinikum St. Pölten, Department of Internal Medicine II, St. Pölten, Austria, 5Darmpraxis Salzburg, Salzburg, Austria, 6Hospital Hall in Tirol, Department of Internal Medicine, Hall in Tirol, Austria, 7Hospital Rudolfstiftung, Department of Internal Medicine IV, Vienna, Austria, 8Hospital Elisabethinen Linz, Department of Internal Medicine IV, Linz, Austria, 9Hospital Wels-Grieskirchen, Department of Internal Medicine I, Wels, Austria, 10Hospital Barmherzige Brüder Salzburg, Department of Internal Medicine, Salzburg, Austria, 11Hospital Wiener Neustadt, Department of Internal Medicine I, Wiener Neustadt, Austria, 12Hartmannspital, Department of Internal Medicine, Vienna, Austria, 13Danube Hospital, Department of Internal Medicine 2, Vienna, Austria, 14Wilheminenspital der Stadt Wien, Department of Internal Medicine 4, Vienna, Austria, 15Medical University of Vienna, Department of Emergency Medicine, Vienna, Austria

P696: Faecal microbiota transplantation in ultra-refractory ulcerative colitis: Retrospective analysis in a tertiary care centreECCO '18 Vienna
Year: 2018
Authors:

A. Guerrero García1*, A. Flores de Miguel1, E. Sánchez Rodríguez1, R. Ríos León1, G. Roy Ariño2, R. Del Campo Moreno3, A. Albillos Martínez1, A. López-Sanromán1

1Ramon y Cajal, Gastroenterology and Hepatology, Madrid, Spain, 2Ramon y Cajal, Inmunology, Madrid, Spain, 3Ramon y Cajal, Microbiology, Madrid, Spain